(1)
CONSTRUCTION OF AN OPTIMAL PORTFOLIO USING THE SINGLE INDEX MODEL: AN EMPIRICAL STUDY OF PRE AND POST COVID 19. Journal of Pharmaceutical Negative Results 2023, 406-417.